About Us

Core Prognostex Inc. was founded by leading cancer researcher, Dr. John Olson, Jr., to improve the important but under-investigated biospecimen “patient-to- platform” link, for the benefit of cancer research, prevention, and treatment efforts. Core Prognostex, Inc. continues to serve the cancer research enterprise with customized and convenient biospecimen acquisition kits.